The global tissue engineered skin substitute market is projected to grow from USD 2.4 billion in 2024 to USD 3.5 billion by 2034, at a CAGR of 3.9%. The rising demand for advanced wound care solutions ...

Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...

ProgenaCare's innovative approach to wound care leverages scientific advancements in biomaterials to deliver effective products for a range of wound types, from acute injuries to chronic conditions.

BioStem expects to finalize definitive agreements within 60 days following customary due diligence. The transaction is subject to regulatory approvals and Board consent. BioStem and ProgenaCare will ...

For breast cancer survivors, we shine a light on a crucial aspect of recovery: the management of wounds and scars ...

The challenges created by industry-wide staffing shortages are widespread, creating stress and frustration for patients and ...

Chrysalis BioTherapeutics, Inc., a clinical stage biopharmaceutical company developing Chrysalin as a Medical Countermeasure and for the treatment of Acute Respiratory Distress Syndrome (ARDS), ...

SurgiBox Inc., a leader in portable surgical solutions, is thrilled to announce a strategic partnership with Japanese medical distribution company, Accord International, to bring its groundbreaking ...

Let’s talk about the lack of connection with our body and how this is closely tied to burnout, plus, what to do about it. So ...

In this prospective cohort of patients with acute myocardial infarction (AMI), plasma progranulin levels increased acutely ...

Organ transplant recipients vs immunocompetent patients had an increased rate of postoperative complications following Mohs micrographic surgery.

Report with market evolution powered by AI - The global wound care market size is estimated to grow by USD 6.95 billion from ...